Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 3, 2021 - Impel NeuroPharma announced the FDA approval of Trudhesa (dihydroergotamine mesylate) nasal spray, for the acute treatment of migraine with or without aura in adults.
Return to publications